Towards Healthcare
U.S. General Surgery Devices Market Surges 8.53% CAGR by 2034

U.S. General Surgery Devices Market Key Players, Strategies and Forecast

Market insights predict the global U.S. general surgery devices industry will increase from USD 5.69 billion in 2024 to USD 12.89 billion by 2034, achieving a CAGR of 8.53%. The U.S. general surgery devices market is expanding due to growing chronic diseases as well as increasing robotic surgeries.

Category: Medical Devices Insight Code: 5662 Format: PDF / PPT / Excel

Shivani Zoting

Principal Consultant

Aditi Shivarkar

Reviewed By

The global U.S. general surgery devices market size is calculated at USD 5.69 in 2024, grew to USD 6.17 billion in 2025, and is projected to reach around USD 12.89 billion by 2034. The market is expanding at a CAGR of 8.53% between 2025 and 2034.

U.S. General Surgery Devices Market Size 2024 - 2034

Key Takeaways

  • U.S. General Surgery Devices sector is pushing the market to USD 5.69 billion in 2024.
  • Long-term projections show USD 12.89 billion valuation by 2034.
  • Growth is expected at a steady CAGR of 8.53% in between 2025 to 2034.
  • The global general surgery devices market is rapidly growing, expected to nearly double from USD 20 billion in 2025 to over USD 41 billion by 2034, with a CAGR of 8.5%.
  • By type, the disposable surgical supplies segment dominated the market share in 2024.
  • By type, the medical robotics & computer-assisted surgery devices segment is estimated to be the fastest growing at a notable CAGR during the forecast period.
  • By application type, the orthopedic surgery segment dominated the market in 2024.
  • By application type, the cardiology segment is anticipated to be the fastest growing during the forecast period.
  • By end user, the hospital segment dominated the U.S. general surgery devices market in 2024.
  • By end user, the ambulatory surgical centers segment is predicted to be the fastest growing during the forecast period.

Key Metrics and Overview

Metric  Details
Market Size in 2025 USD 6.17 Billion
Projected Market Size in 2034 USD 12.89 Billion
CAGR (2025 - 2034) 8.53%
Market Segmentation By Type, By Application, By End-use
Top Key Players Johnson & Johnson Service, Inc., Conmed Corporation, B. Braun Melsungen Ag, Medtronic Plc, Becton, Dickinson and Company (Bd), Integra LifeSciences, Boston Scientific Corporation, Smith & Nephew, Integer Holdings Corporation, Cadence Inc, Olympus Corporation, Stryker, 3M Healthcare, Erbe Elektromedizin Gmbh

U.S. General Surgery Devices Market Overview

The surgical medical devices are used to monitor, diagnose, alleviate, treat, or prevent any disease or injury. They can be instruments, apparatus, or implants used during the surgeries. Furthermore, the use of these surgical devices helps in improving the surgical outcomes by enhancing the performance of the surgeries. Moreover, these devices can be simple tools such as forceps or scalpels, or complex machinery such as laparoscopic equipment or surgical robots. Thus, these devices help the surgeons during the operations with enhanced efficiency and precision, which leads to improved patient outcomes.

The Global General Surgery Devices Market

The global general surgery devices market size was valued at USD 18.44 billion in 2024 and grew to USD 20.01 billion in 2025. It is expected to nearly double, reaching approximately USD 41.57 billion by 2034. This growth reflects a steady annual increase of about 8.5% between 2025 and 2034.

General Surgery Devices Market Size 2023 - 2034

  • In May 2025, the first procedure for the TricValve System was completed by the collaboration between Tampa General Hospital (TGH) and USF Health in Florida under the FDA Early Feasibility Study. The use of these medical devices was evaluated in patients with severe Tricuspid Regurgitation (TR), which is a life-threatening cardiac condition. (Source - PHARMABIZ)
  • In May 2025, an agreement between Optiscan and the Mayo Clinic developed a digital confocal laser endomicroscopic imaging system for breast cancer, which will be used in robotic surgery. The tissue classification, cancer margin assessment, and cancer cell determination will be enhanced with the use of this system, as it will offer real-time, high-resolution microscopic-level imaging in robotic-assisted surgical procedures, as its main goal.

AI Integration in the U.S. General Surgery Devices Market

The integration of AI in general surgery devices helps in transforming healthcare. The preoperative planning, intraoperative guidance, as well as postoperative care can be improved with the use of AI. At the same time, deep learning (DL), machine learning (ML), as well as robotic-assisted surgery also contribute to the AI-driven innovations used during surgeries. These innovations help in minimizing manual errors, predicting complications, as well as help in decision making depending on the data gathered and interpreted. Thus, the use of AI in general surgery devices improves patient outcomes.

Market Dynamics

Driver

Increasing Chronic Diseases

There is a rise in the occurrence of various chronic diseases such as cancer, cardiovascular disease, diabetes, etc. These diseases increase the demand for early diagnosis as well as effective treatment and monitoring. At the same time, they also increase the need for surgeries. Hence, this in turn contributes to the rise in the use of various surgical devices for enhancing the surgical procedures, along with the patient outcomes. Furthermore, the use of these advanced surgical devices also helps in improving the accuracy as well as the speed of recovery. Thus, all these factors drive the U.S. general surgery devices market growth.

Total No. of Cancer Deaths in U.S. in 2024

The graph represents the total number of cancer deaths in the U.S. in the year of 2024. It indicates that there will be a rise in cancer cases. Hence, it increases the demand for various surgical devices for its effective diagnosis, management, and treatment. Thus, this in turn will ultimately promote the market growth. (Source - American Cancer Society)

Restraint

Strict Approval Process

During the approval process of any surgical device, strict clinical trials are conducted by the U.S. FDA. These trials take a long period, which in turn also increases the investments by the companies for conducting the trials. Furthermore, the devices developed may not always be approved, which impacts the research, as well as the innovation conducted, limiting the development of new surgical devices. Along with these factors, the complexities of trials also affect the growth of the market.

Opportunity

Robotic Surgeries

The diseases or injuries that require surgery are often associated with various complications, due to which the demand for robotic-assisted surgeries is increasing. With the help of robotic-assisted systems, the diagnosis as well as the monitoring of diseases are improving. At the same time, it also helps in minimally invasive surgeries, enhancing the patient outcomes as well as the accuracy of the surgeries. Furthermore, various complex surgeries are also conducted effectively with the use of these robotic-assisted systems. Thus, all these factors promote their use, as well as the U.S. general surgery devices market growth.

For instance,

  • In May 2025, a Breakthrough Device Designation was granted by the U.S. FDA to Elucent Medical for its EnVisio X1™ In-Body Spatial Intelligence™ System. This system helps in real-time 3D guidance for resection and margin control, as well as robotic-assisted and video surgeries. This, in turn, helps in enhancing the soft tissue excisions of the abdominal and thoracic cavities. (Source - The Manali Times)

Segmental Insights

Disposable Surgical Supplies Segment Led in 2024

By type, the disposable surgical supplies segment dominated the market in 2024. The disposable surgical supplies were single-use supplies that reduced the risk of infections within patients. Furthermore, they were affordable and convenient to use, as well as reducing the need for sterilization. Thus, it contributed to the U.S. general surgery devices market growth.

Medical Robotics & Computer-Assisted Surgery Devices Segment: Fastest Growing

By type, the medical robotics & computer-assisted surgery devices segment is estimated to be the fastest growing at a notable CAGR during the forecast period. These devices enhance the accuracy of the surgeons, which in turn, enhances the patient outcomes. This, in turn, increases their use in complex, as well as minimally invasive surgeries.

Orthopedic Surgery Segment Dominated in 2024

By application type, the orthopedic surgery segment dominated the market in 2024. Due to increasing orthopedic disorders, injuries, as well as an aging population, there was an increased use of various surgical devices. At the same time, the development of new devices also contributed to the U.S. general surgery devices market growth.

Cardiology Segment: Fastest Growing

By application type, the cardiology segment is anticipated to be the fastest growing during the forecast period. The use of surgical devices in cardiology applications is rising due to growing awareness as well as rising rates of various cardiological disorders. This, in turn, enhances the use of early diagnosis, monitoring, as well as treatment associated with surgical devices.

Hospital Segment Held the Major Share in 2024

By end user, the hospital segment dominated the U.S. general surgery devices market in 2024. The hospital consisted of advanced technological surgical devices as well as skilled personnel, which improved the performance of the surgeries. At the same time, a large volume of patients with diverse diseases were effectively treated, which enhanced the patient outcomes as well as market growth.

Ambulatory Surgical Centers Segment: Fastest Growing

By end user, the ambulatory surgical centers segment is predicted to be the fastest growing during the forecast period. The patients are preferring ambulatory surgical centers, due to the presence of advanced surgical devices which provide fast surgeries as well as accelerate the recovery time. At the same time, the affordability also contributes to the same.

Increasing Adoption of Surgical Devices Drives the U.S.

The U.S. general surgery devices market is estimated to grow significantly during the forecast period. The U.S. is experiencing a rise in the demand for the use of various surgical devices due to increasing disease prevalence. At the same time, the adoption of new technologies is also contributing to the same. Furthermore, the well-developed healthcare sector is utilizing new surgical devices to improve the success rates of the surgeries. The use of minimally invasive surgeries, as well as robotic surgeries, is also increasing. Furthermore, the reimbursement policies are also attracting the population. Thus, all these factors promote the market growth.

Top Companies in the U.S. General Surgery Devices Market

U.S. General Surgery Devices Market Companies

What are the Latest Announcements by Industry Leaders in the U.S. General Surgery Devices Market?

  • In May 2025, the HYALEX Freestyle Knee Implant, developed by Hyalex Orthopaedics, received approval for a clinical trial by the US Food and Drug Administration (FDA). Hence, Carl Vause, Hyalex Orthopaedics CEO, stated that, for the unmet needs of patients with cartilage gaps, they will offer innovative solutions, which will show their commitment to advancing orthopaedic care. He further stated that they anticipate that a $2bn market will be represented by the U.S. alone. 
  • In May 2025, a transcatheter tricuspid valve replacement (TTVR) was completed by the SMH interventional cardiologists, Drs. Ricardo Yayura, Fabio Lima, and Jeffrey Rossi, where Dr. Rossi stated that open heart surgery is not necessary while using the Evoque TTVR system, as it is less invasive. The improvement in the symptoms as well as quality of life is achieved by this system, as its procedure requires 2 hrs, with fast recovery rates where the patients are discharged in 2 or 3 days.

What are the Recent Developments in the U.S. General Surgery Devices Market?

  • In May 2025, plans to submit a de novo classification request in July by SS Innovations for its SSi Mantra 3 surgical robotic system to the U.S. FDA are in process. The applications for multi-specialty indications, such as general surgery, urology, thoracic surgery, cardiac surgery, and gynecology, will be included in the submission. (Source - The Robot Report)
  • In May 2025, the safety and effectiveness endpoints were met for the Expand URO Investigational New Drug (IND) clinical study conducted for robotic-assisted urological surgery by Medtronic. This IDE study consisted of 137 patients who received the HugoTM robotic-assisted surgery (RAS) system for a urologic procedure. (Source - IANS)

Segments Covered in the Report

By Type

  • Disposable Surgical Supplies
    • Surgical Non-woven
      • Disposable Surgical Masks
      • Surgical Drapes
      • Surgical Caps
      • Surgical Gowns
    • Examination & Surgical Gloves
    • General Surgery Procedural Kits
    • Needles and Syringes
    • Venous Access Catheters
  • Open Surgery Instrument
    • Retractor
    • Dilator
    • Catheters
  • Energy-based & Powered Instrument
    • Powered Staplers
    • Drill System
  • Minimally Invasive Surgery Instruments
    • Laparoscope
    • Organ Retractor
  • Medical Robotics & Computer-Assisted Surgery Devices
  • Adhesion Prevention Products

By Application

  • Orthopedic Surgery
  • Cardiology
  • Ophthalmology
  • Wound Care
  • Audiology
  • Thoracic Surgery
  • Urology and Gynecology Surgery
  • Plastic Surgery
  • Neurosurgery
  • Others

By End-use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Last Updated: 30 May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Shivani Zoting is a healthcare market research expert with 2+ years of experience, specializing in analyzing trends, identifying growth opportunities, and providing actionable insights for businesses across healthcare sectors.

Learn more about Shivani Zoting

Aditi Shivarkar, with over 14 years of experience in consumer goods, leads research at Towards Consumer Goods, ensuring precise, actionable insights on trends, consumer preferences, and sustainable packaging for businesses.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

The disposable surgical supplies are commonly used as they are single-use devices, which reduces the risk of infection as well as the need for sterilization, enhancing the convenience for the surgeons.

Increasing chronic diseases are the factor that drives the market.

American Cancer Society, National Institutes of Health, FDA, WHO, CDC.